quantisnow
FeedTopReportsPricing
⌘K
Live feed
06:07:01·57d
SECFiling
Anavex Life Sciences Corp. logo

Anavex Life Sciences Corp. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

AVXL· Anavex Life Sciences Corp.
Health Care
Original source

Companies

  • AVXL
    Anavex Life Sciences Corp.
    Health Care

Recent analyst ratings

  • Dec 6UpdateCantor Fitzgerald$11.00
  • Jun 23UpdateBerenberg$40.00
  • Feb 2UpdateHC Wainwright & Co.$42.00
  • Sep 23UpdateBTIG Research$35.00
  • Jun 28UpdateHC Wainwright & Co.$39.00

Related

  • PR9d
    Anavex Life Sciences Highlights New Scientific Findings on Shared Biology Between Autism and Alzheimer's Disease
  • PR16d
    Anavex Life Sciences to Present at the 25th Annual Needham Virtual Healthcare Conference
  • PR24d
    Anavex Life Sciences Provides Comprehensive Regulatory Update
  • SEC28d
    Amendment: SEC Form SCHEDULE 13G/A filed by Anavex Life Sciences Corp.
  • SEC29d
    Anavex Life Sciences Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
  • PR29d
    Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer's Disease
  • PR31d
    Anavex Life Sciences Presents New Data from its AD-004 Phase IIb/III Trial at AD/PD 2026 Conference Demonstrating Consistent Correlation Between the Treatment Effect of Oral Blarcamesine and Preservation of Brain Volume in Early Alzheimer's Disease
  • PR34d
    New Scientific Findings Highlight Hypothesis of Autophagy Failure as a Precursor of Amyloid Beta and Tau Pathology in Alzheimer's Disease
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022